Centessa Pharmaceuticals
Ejecutivos
Ver el organigrama con sus 19 ejecutivos principales
Biografías más buscadas en Centessa Pharmaceuticals
- Saurabh Saha, Chief Executive Officer and Director
- Francesco De Rubertis, Chairman of The Board
- Mary Hedley, Director
Recientes movimientos de ejecutivos en Centessa Pharmaceuticals
- Ellie Im, se ha incorporado a la empresa como Senior Vice President of Clinical Development, Oncology (noticia publicada el 3 de octubre de 2023).
- April Dovholuk, se ha incorporado a la empresa como Senior Vice President of Development Operations (noticia publicada el 3 de octubre de 2023).
Crear su alerta
para seguir los movimientos de los ejecutivos en Centessa Pharmaceuticals.
Farmacia
Centessa Pharmaceuticals tiene 1.863 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacia
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
- Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Addition of Harris L. Rotman, PhD, as Senior Vice President of Regulatory Affairs | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors | Centessa Pharmaceuticals
- Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Makes Strategic Decision to Discontinue Clinical Development of Lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Doses First Subject in Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise | Centessa Pharmaceuticals
- Centessa Pharmaceuticals to Present at the Guggenheim Genomic Medicines & Rare Disease Day | Centessa Pharmaceuticals
- View more press releases Close
Redes sociales sobre Centessa Pharmaceuticals
- Centessa Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Centessa Pharmaceuticals en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Saurabh Saha 
Llame a Centessa Pharmaceuticals al +1 857...
